Multi-Center Study Evaluating OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
United States: Food and Drug Administration
C25608/3039/BP/US
NCT00105287
February 2004
Name | Location |
---|---|
Lehigh Valley Hospital | Allentown, Pennsylvania 18103 |
Advanced Clinical Research Institute | Anaheim, California 92801 |
University of Pennsylvania | Philadelphia, Pennsylvania 19104 |
Pacific Clinical Research | Santa Monica, California 90404 |
Gabrail Cancer Center | Canton, Ohio 44718 |
Clinical Trials & Research Associates, Inc. | Montebello, California 90640 |
Hematology Oncology Associates of Treasure Coast | Port St. Lucie, Florida 34952 |
NYU Pain Management Center | New York, New York 10016 |
Lifetree Clinical Research | Salt Lake City, Utah 84106 |
Great Falls Clinic, LLP | Great Falls, Montana 59405 |
Charleston Hematology Oncology, PA | Charleston, South Carolina 29403 |
Pacific Cancer Medical Center | Anaheim, California 92801 |
Cullman Oncology and Hematology | Cullman, Alabama 35058 |
Compassionate Cancer Care Medical Group | Corona, California 92882 |
Compassionate Cancer Center | Fountain Valley, California 92708 |
San Diego Hospice & Palliative Care | San Diego, California 92103 |
Lovelace Scientific Resources | Miami, Florida 33143 |
Gulf Coast Pain Specialists | Pensacola, Florida 32503 |
Center for Prospective Outcome | Marietta, Georgia 30060 |
Iowa Pain Management Clinic, PC | Des Moines, Iowa 50265 |
Donald Berdeaux | Great Falls, Montana 59405 |
Southern Nevada Cancer Research | Las Vegas, Nevada 89106 |
Research Across America | New York, New York 10021 |
Brody School of Medicine | Greenville, North Carolina 27858 |
University of Rochester | San Antonio, Texas 78229 |
Cache Valley Cancer Treatment and Research Clinic, Inc. | West Point, Utah 84015 |